首页> 美国卫生研究院文献>other >A Pharmacokinetic and Pharmacodynamic Study of Delayed- and Extended-Release Hydrocortisone (Chronocort™) versus Conventional Hydrocortisone (Cortef™) in the Treatment of Congenital Adrenal Hyperplasia

【2h】

A Pharmacokinetic and Pharmacodynamic Study of Delayed- and Extended-Release Hydrocortisone (Chronocort™) versus Conventional Hydrocortisone (Cortef™) in the Treatment of Congenital Adrenal Hyperplasia

机译：延迟和延长释放氢化鞘（Chronocort TM）对常规氢化体（Cortef TM）治疗先天性肾上腺增生的药代动力学和药效学研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

SummaryObjectiveExisting glucocorticoid treatment for congenital adrenal hyperplasia (CAH) is suboptimal and nonphysiological. We compared hormonal profiles during therapy with a new modified-release hydrocortisone (MR-HC), Chronocort™, to conventional hydrocortisone (HC), Cortef™, in patients with CAH.

著录项

期刊名称 other
作者
Somya Verma; Carol VanRyzin; Ninet Sinaii; Mimi S. Kim; Lynnette K. Nieman; Shayna Ravindran; Karim A. Calis; Wiebke Arlt; Richard J. Ross; Deborah P. Merke;
展开▼
作者单位

展开▼
年(卷),期 -1(72),4
年度 -1
页码 441–447
总页数 14
原文格式 PDF
正文语种
中图分类
关键词
hydrocortisone pharmacokinetic circadian Congenital Adrenal Hyperplasia CAH;

机译：氢化可的松;药代动力学;昼夜节律;先天性肾上腺增生;CAH;

相似文献

外文文献
专利

1. A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort~(TM)) vs. conventional hydrocortisone (Cortef~(TM)) in the treatment of congenital adrenal hyperplasia [J] . Somya Verma, Carol VanRyzin, Ninet Sinaii Clinical Endocrinology . 2010 ,第4期

机译：延迟和延长释放氢化可的松（Chronocort〜）与常规氢化可的松（Cortef〜）的药代动力学和药效学研究治疗先天性肾上腺皮质增生
2. A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (ChronocortTM) vs. conventional hydrocortisone (CortefTM) in the treatment of congenital adrenal hyperplasia [J] . Somya Verma, Carol VanRyzin, Ninet Sinaii, Clinical Endocrinology . 2010 ,第4期

机译：缓释和缓释氢化可的松（Chronocort TM ）与常规氢化可的松（Cortef TM ）治疗先天性肾上腺皮质增生的药代动力学和药效学研究
3. Pharmacokinetic/pharmacodynamics analysis of hydrocortisone in pediatric patients with congenital adrenal hyperplasia [J] . Melin Johanna, Truong Thi, Hindmarsh Peter, Journal of pharmacokinetics and pharmacodynamics . 2016 ,第Suppla期

机译：氢化可的松在小儿先天性肾上腺皮质增生患者中的药代动力学/药效学分析
4. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency A paradigm for prenatal diagnosis and treatment [C] . Saroj Nimkarn, Maria I. New Conference on Skeletal Biology and Medicine . 2010

机译：先天性肾上腺素增生由于21羟化酶缺乏症的产前诊断和治疗范式
5. Pharmacokinetic and pharmacodynamic studies of gamma-hydroxybutyric acid (GHB): Toxicity treatment and tolerance development. [D] . Bhattacharya, Indranil. 2006

机译：γ-羟基丁酸（GHB）的药代动力学和药效学研究：毒性治疗和耐受性发展。
6. A Phase 2 Study of Chronocort a Modified-Release Formulation of Hydrocortisone in the Treatment of Adults With Classic Congenital Adrenal Hyperplasia [O] . Ashwini Mallappa, Ninet Sinaii, Parag Kumar, -1

机译：Chronocort（氢化可的松的改良发行制剂）在成人经典先天性肾上腺增生症治疗中的2期研究
7. A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (ChronocortTM)vs.conventional hydrocortisone (CortefTM) in the treatment of congenital adrenal hyperplasia [O] . Somya Verma, Carol VanRyzin, Ninet Sinaii, 2010

机译：延迟和延长释放氢化胞嘧啶（Chronocorttm）vs.Corpentional氢化胞苷（Corteftm）治疗先天性肾上腺增生的药代动力学和药效学研究

A Pharmacokinetic and Pharmacodynamic Study of Delayed- and Extended-Release Hydrocortisone (Chronocort™) versus Conventional Hydrocortisone (Cortef™) in the Treatment of Congenital Adrenal Hyperplasia

摘要

著录项

相似文献

相关主题

期刊订阅